Old Web
English
Sign In
Acemap
>
Paper
>
Abstract 4806: Exploring optimal targeted combination therapies with neratinib for HER2 mutated NSCLC
Abstract 4806: Exploring optimal targeted combination therapies with neratinib for HER2 mutated NSCLC
2018
Mari Kuraguchi
Luke J. Taus
Shan Zhou
Francesca Avogadri-Connors
Richard E. Cutler
Alshad S. Lalani
Paul Kirschmeier
Pasi A. Jänne
Keywords:
Neratinib
Immunology
Cancer research
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]